Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intellia Therapeutics (NTLA) Tax Provisions: 2015

Historic Tax Provisions for Intellia Therapeutics (NTLA) over the last 1 years, with Dec 2015 value amounting to -$1.0 million.

  • Intellia Therapeutics' Tax Provisions was N/A to -$246,000 in Q4 2015 from the same period last year, while for Dec 2015 it was -$1.0 million, marking a year-over-year change of. This contributed to the annual value of -$1.0 million for FY2015, which is N/A change from last year.
  • Intellia Therapeutics' Tax Provisions amounted to -$1.0 million in FY2015.
  • Intellia Therapeutics' Tax Provisions' 5-year high stood at -$1.0 million during FY2015, with a 5-year trough of -$1.0 million in FY2015.
  • Over the past 1 years, Intellia Therapeutics' median Tax Provisions value was -$1.0 million (recorded in 2015), while the average stood at -$1.0 million.